Yan Jiayi, Ruan Panpan, Ge Yunxuan, Gao Jing, Tan Hongling, Xiao Chengrong, Gao Quansheng, Zhang Zhuo, Gao Yue
School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
ACS Omega. 2021 Oct 5;6(41):26942-26951. doi: 10.1021/acsomega.1c03282. eCollection 2021 Oct 19.
Compound Danshen dropping pill (CDDP), a famous Chinese medicine formula, has been widely used to treat high-altitude heart disease in China. However, its molecular mechanisms, potential targets, and bioactive ingredients remain elusive. In this study, network pharmacology, molecular docking, and validation experiments were combined to investigate the effective active ingredients and molecular mechanisms of CDDP in the treatment of high-altitude heart disease. Tan IIA may be the main active component of CDDP in the treatment of high-altitude heart disease via HIF-1/PI3K/Akt pathways.
复方丹参滴丸(CDDP)是一种著名的中药配方,在中国已被广泛用于治疗高原心脏病。然而,其分子机制、潜在靶点和生物活性成分仍不清楚。在本研究中,结合网络药理学、分子对接和验证实验,研究CDDP治疗高原心脏病的有效活性成分和分子机制。丹参酮IIA可能是CDDP通过HIF-1/PI3K/Akt途径治疗高原心脏病的主要活性成分。